YI Earnings Date: Nov 26, 2026 (Estimated) — 111, Inc.
NASDAQ · Healthcare · Medical Distribution
Updated
When is YI's next earnings date?
111, Inc. (YI) is expected to report Q3 2026 earnings on Thursday, November 26, 2026 at 1:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company.
How did YI do in its last earnings report?
In its most recent report on Sep 17, 2026 (Q2 2026), 111, Inc. posted EPS of -$0.60. Revenue was $339.0M. The stock's 1-day post-earnings move was +4.7%.
How much does YI stock move after earnings?
Over the last 8 reports the stock moved an average of 11.5% (up or down) in the day after earnings.
About 111, Inc.
Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 | Q2 2026 | — | -0.60 | — | $339.0M | — | +4.73% | +9.76% | -8.58% |
| 2026-06-04 | Q1 2026 | — | -0.60 | — | $342.4M | — | -10.27% | -17.11% | -25.38% |
| 2026-04-09 | Q4 2025 | — | -0.20 | — | $403.3M | — | -1.08% | +7.87% | -13.89% |
| 2025-12-17 | Q3 2025 | — | -0.20 | — | $421.5M | — | +2.93% | -12.86% | +65.21% |
| 2025-09-17 | Q2 2025 | — | -0.40 | — | $447.5M | — | -6.24% | -19.85% | -28.43% |
| 2025-03-20 | Q4 2024 | — | -0.04 | — | $527.1M | — | -7.82% | -10.36% | -31.82% |
| 2024-11-27 | Q3 2024 | — | -0.20 | — | $513.1M | — | +49.54% | +25.18% | +19.49% |
| 2024-08-29 | Q2 2024 | — | -0.20 | — | $471.2M | — | -9.30% | -23.23% | -13.36% |
Showing last 8 quarters.
Revenue by segment & region
By segment
FY2025 · $25.11B total · annual
| Segment | Share | Revenue | YoY | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|
| Product | 49.7% | $12.47B | -12.8% | $3.93B | $8.16B | $12.33B | $13.40B |
| Drugs | 46.4% | $11.65B | -13.0% | $3.60B | $7.40B | $11.68B | $12.57B |
| Nutritional Supplements | 1.7% | $434.7M | -21.0% | $245.6M | $559.2M | — | $554.8M |
| Other Products | 0.9% | $233.7M | +15.8% | $20.3M | $46.5M | — | $111.1M |
| Medical Supplies And Devices | 0.6% | $152.4M | +5.6% | $50.2M | $149.1M | — | $164.9M |
| Service | 0.3% | $85.4M | -19.8% | $22.4M | $46.5M | $94.2M | $113.3M |
| MP Service | 0.2% | $56.7M | -13.4% | — | — | $52.3M | $68.5M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.